Crisprqc
San Diego, US · Founded 2021 · Delaware corporation · 11 employees on LinkedIn · 2 known investors
Founders & leadership
RB
Ross BundyExecutive
KA
Kiana AranNamed on SEC filing
MH
Michael HeltzenNamed on SEC filing
Board
GB
George BonarosBoard director
PG
Paul GrintBoard director
TR
Toby RichardsonBoard director
CY
Chris YooBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$4.8M disclosed across 2 rounds · 2022–2024
▶$3.9MraisedApr 2025 · 14 investors · BiotechnologyRule 506(b)
▶$3.9MraisedApr 2025 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ross BundyExecutive Officer, Director
- George BonarosDirector
- Paul GrintDirector
- Kiana AranDirector
- Toby RichardsonDirector
- Chris YooDirector
- Offering amount
- $10M
- Amount sold
- $3.9M
- Minimum investment
- $5K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$885KraisedMar 2022 · 7 investors · BiotechnologyRule 506(b)
▶$885KraisedMar 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HeltzenDirector
- Ross Helgren BundyExecutive Officer
- Kiana AranDirector
- Offering amount
- $4M
- Amount sold
- $885K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Synthego10 shared keywordsSynthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems. It serves researchers and cell and gene therapy developers in the biotechnology industry.
CRISPR9 shared keywordsCRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.
Oup4 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Companies competing with Crisprqc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are Crisprqc's investors?
- Crisprqc's investors include BioBrit, Serra Ventures.
- How much funding has Crisprqc raised?
- Crisprqc has disclosed $4.8M raised across 2 rounds.
- Where is Crisprqc headquartered?
- Crisprqc is headquartered in San Diego, US.